Sfoglia per Autore
Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle
2023-01-01 Azzimonti B.; Ballacchino C.; Zanetta P.; Cucci M.A.; Monge C.; Grattarola M.; Dianzani C.; Barrera G.; Pizzimenti S.
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
2023-01-01 Cucci M.A.; Grattarola M.; Monge C.; Roetto A.; Barrera G.; Caputo E.; Dianzani C.; Pizzimenti S.
MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities
2022-01-01 Sequera, Celia; Grattarola, Margherita; Holczbauer, Agnes; Dono, Rosanna; Pizzimenti, Stefania; Barrera, Giuseppina; Wangensteen, Kirk J; Maina, Flavio
Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells
2021-01-01 Grattarola M.; Cucci M.A.; Roetto A.; Dianzani C.; Barrera G.; Pizzimenti S.
Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies
2021-01-01 Pizzimenti S.; Ribero S.; Cucci M.A.; Grattarola M.; Monge C.; Dianzani C.; Barrera G.; Muzio G.
Peroxisome proliferator-activated receptors (Ppars) and oxidative stress in physiological conditions and in cancer
2021-01-01 Muzio G.; Barrera G.; Pizzimenti S.
Nrf2, YAP, antioxidant potential, and cancer
2021-01-01 Giuseppina Barrera, Marie Angele Cucci, Margherita Grattarola, Stefania Pizzimenti
Control of oxidative stress in cancer chemoresistance: spotlight on Nrf2 role
2021-01-01 Barrera G.; Cucci M.A.; Grattarola M.; Dianzani C.; Muzio G.; Pizzimenti S.
Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver
2020-01-01 Daga M.; de Graaf I.A.M.; Argenziano M.; Barranco A.S.M.; Loeck M.; Al-Adwi Y.; Cucci M.A.; Caldera F.; Trotta F.; Barrera G.; Casini A.; Cavalli R.; Pizzimenti S.
Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models
2020-01-01 Argenziano M.; Gigliotti C.L.; Clemente N.; Boggio E.; Ferrara B.; Trotta F.; Pizzimenti S.; Barrera G.; Boldorini R.; Bessone F.; Dianzani U.; Cavalli R.; Dianzani C.
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism
2020-01-01 Cucci M.A.; Grattarola M.; Dianzani C.; Damia G.; Ricci F.; Roetto A.; Trotta F.; Barrera G.; Pizzimenti S.
Carbosilane dendrimers loaded with sirna targeting nrf2 as a tool to overcome cisplatin chemoresistance in bladder cancer cells
2020-01-01 Ambrosio L.; Argenziano M.; Cucci M.A.; Grattarola M.; de Graaf I.A.M.; Dianzani C.; Barrera G.; Nieves J.S.; Gomez R.; Cavalli R.; Pizzimenti S.
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells
2019-01-01 Cucci M.A.; Compagnone A.; Daga M.; Grattarola M.; Ullio C.; Roetto A.; Palmieri A.; Rosa A.C.; Argenziano M.; Cavalli R.; Simile M.M.; Pascale R.M.; Dianzani C.; Barrera G.; Pizzimenti S.
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression
2019-01-01 Daga, Martina; Pizzimenti, Stefania*; Dianzani, Chiara; Cucci, Marie Angele; Cavalli, Roberta; Grattarola, Margherita; Ferrara, Benedetta; Scariot, Valentina; Trotta, Francesco; Barrera, Giuseppina
Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastatic spreading in prostate cancer cells
2019-01-01 Bessone, F.; Argenziano, M.; Grillo, G.; Ferrara, B.; Pizzimenti, S.; Barrera, G.; Cravotto, G.; Guiot, C.; Stura, I.; Cavalli, R.; Dianzani, C.
Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells
2019-01-01 Girek M.; Klosinski K.; Grobelski B.; Pizzimenti S.; Cucci M.A.; Daga M.; Barrera G.; Pasieka Z.; Czarnecka K.; Szymanski P.
Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models
2019-01-01 Clemente, Nausicaa; Argenziano, Monica; Gigliotti, Casimiro Luca; Ferrara, Benedetta; Boggio, Elena; Chiocchetti, Annalisa; Caldera, Fabrizio; Trotta, Francesco; Benetti, Elisa; Annaratone, Laura; Ribero, Simone; Pizzimenti, Stefania; Barrera, Giuseppina; Dianzani, Umberto; Cavalli, Roberta; Dianzani, Chiara
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease
2018-01-01 Antognelli, Cinzia*; Trapani, Eliana; Delle Monache, Simona; Perrelli, Andrea; Daga, Martina; Pizzimenti, Stefania; Barrera, Giuseppina; Cassoni, Paola; Angelucci, Adriano; Trabalzini, Lorenza; Talesa, Vincenzo Nicola; Goitre, Luca; Retta, Saverio Francesco
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer
2018-01-01 Ciamporcero, Eric; Daga, Martina; Pizzimenti, Stefania; Roetto, Antonella; Dianzani, Chiara; Compagnone, Alessandra; Palmieri, Antonietta; Ullio, Chiara; Cangemi, Luigi; Pili, Roberto; Barrera, Giuseppina
Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders
2018-01-01 Giuseppina Barrera, Stefania Pizzimenti, Martina Daga, Chiara Dianzani, Alessia Arcaro, Giovanni Paolo Cetrangolo, Giulio Giordano, Marie Angele Cucci, Maria Graf, Fabrizio Gentile
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle | 2023 | Azzimonti B.; Ballacchino C.; Zanetta P.; Cucci M.A.; Monge C.; Grattarola M.; Dianzani C.; Barrera G.; Pizzimenti S. | |
| Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma | 2023 | Cucci M.A.; Grattarola M.; Monge C.; Roetto A.; Barrera G.; Caputo E.; Dianzani C.; Pizzimenti S. | |
| MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities | 2022 | Sequera, Celia; Grattarola, Margherita; Holczbauer, Agnes; Dono, Rosanna; Pizzimenti, Stefania; Barrera, Giuseppina; Wangensteen, Kirk J; Maina, Flavio | |
| Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells | 2021 | Grattarola M.; Cucci M.A.; Roetto A.; Dianzani C.; Barrera G.; Pizzimenti S. | |
| Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies | 2021 | Pizzimenti S.; Ribero S.; Cucci M.A.; Grattarola M.; Monge C.; Dianzani C.; Barrera G.; Muzio G. | |
| Peroxisome proliferator-activated receptors (Ppars) and oxidative stress in physiological conditions and in cancer | 2021 | Muzio G.; Barrera G.; Pizzimenti S. | |
| Nrf2, YAP, antioxidant potential, and cancer | 2021 | Giuseppina Barrera, Marie Angele Cucci, Margherita Grattarola, Stefania Pizzimenti | |
| Control of oxidative stress in cancer chemoresistance: spotlight on Nrf2 role | 2021 | Barrera G.; Cucci M.A.; Grattarola M.; Dianzani C.; Muzio G.; Pizzimenti S. | |
| Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver | 2020 | Daga M.; de Graaf I.A.M.; Argenziano M.; Barranco A.S.M.; Loeck M.; Al-Adwi Y.; Cucci M.A.; Caldera F.; Trotta F.; Barrera G.; Casini A.; Cavalli R.; Pizzimenti S. | |
| Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models | 2020 | Argenziano M.; Gigliotti C.L.; Clemente N.; Boggio E.; Ferrara B.; Trotta F.; Pizzimenti S.; Barrera G.; Boldorini R.; Bessone F.; Dianzani U.; Cavalli R.; Dianzani C. | |
| Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism | 2020 | Cucci M.A.; Grattarola M.; Dianzani C.; Damia G.; Ricci F.; Roetto A.; Trotta F.; Barrera G.; Pizzimenti S. | |
| Carbosilane dendrimers loaded with sirna targeting nrf2 as a tool to overcome cisplatin chemoresistance in bladder cancer cells | 2020 | Ambrosio L.; Argenziano M.; Cucci M.A.; Grattarola M.; de Graaf I.A.M.; Dianzani C.; Barrera G.; Nieves J.S.; Gomez R.; Cavalli R.; Pizzimenti S. | |
| Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells | 2019 | Cucci M.A.; Compagnone A.; Daga M.; Grattarola M.; Ullio C.; Roetto A.; Palmieri A.; Rosa A.C.; Argenziano M.; Cavalli R.; Simile M.M.; Pascale R.M.; Dianzani C.; Barrera G.; Pizzimenti S. | |
| Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression | 2019 | Daga, Martina; Pizzimenti, Stefania*; Dianzani, Chiara; Cucci, Marie Angele; Cavalli, Roberta; Grattarola, Margherita; Ferrara, Benedetta; Scariot, Valentina; Trotta, Francesco; Barrera, Giuseppina | |
| Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastatic spreading in prostate cancer cells | 2019 | Bessone, F.; Argenziano, M.; Grillo, G.; Ferrara, B.; Pizzimenti, S.; Barrera, G.; Cravotto, G.; Guiot, C.; Stura, I.; Cavalli, R.; Dianzani, C. | |
| Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells | 2019 | Girek M.; Klosinski K.; Grobelski B.; Pizzimenti S.; Cucci M.A.; Daga M.; Barrera G.; Pasieka Z.; Czarnecka K.; Szymanski P. | |
| Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models | 2019 | Clemente, Nausicaa; Argenziano, Monica; Gigliotti, Casimiro Luca; Ferrara, Benedetta; Boggio, Elena; Chiocchetti, Annalisa; Caldera, Fabrizio; Trotta, Francesco; Benetti, Elisa; Annaratone, Laura; Ribero, Simone; Pizzimenti, Stefania; Barrera, Giuseppina; Dianzani, Umberto; Cavalli, Roberta; Dianzani, Chiara | |
| KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease | 2018 | Antognelli, Cinzia*; Trapani, Eliana; Delle Monache, Simona; Perrelli, Andrea; Daga, Martina; Pizzimenti, Stefania; Barrera, Giuseppina; Cassoni, Paola; Angelucci, Adriano; Trabalzini, Lorenza; Talesa, Vincenzo Nicola; Goitre, Luca; Retta, Saverio Francesco | |
| Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer | 2018 | Ciamporcero, Eric; Daga, Martina; Pizzimenti, Stefania; Roetto, Antonella; Dianzani, Chiara; Compagnone, Alessandra; Palmieri, Antonietta; Ullio, Chiara; Cangemi, Luigi; Pili, Roberto; Barrera, Giuseppina | |
| Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders | 2018 | Giuseppina Barrera, Stefania Pizzimenti, Martina Daga, Chiara Dianzani, Alessia Arcaro, Giovanni Paolo Cetrangolo, Giulio Giordano, Marie Angele Cucci, Maria Graf, Fabrizio Gentile |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile